BriaCell Therapeutics Corp. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BriaCell Therapeutics Corp. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q2 2021 to Q1 2024.
  • BriaCell Therapeutics Corp. Retained Earnings (Accumulated Deficit) for the quarter ending April 30, 2024 was -$84.2M, a 7.66% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$84.2M -$6M -7.66% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$85.9M -$12.6M -17.2% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$74.7M -$13.2M -21.5% Oct 31, 2023 10-Q 2023-12-14
Q2 2023 -$80.7M -$20.3M -33.6% Jul 31, 2023 10-Q 2024-06-14
Q1 2023 -$78.2M Apr 30, 2023 10-Q 2023-06-14
Q4 2022 -$73.3M Jan 31, 2023 10-Q 2023-03-16
Q3 2022 -$61.5M Oct 31, 2022 10-Q 2022-12-14
Q2 2022 -$60.3M -$31.2M -107% Jul 31, 2022 10-K 2023-10-25
Q2 2021 -$29.1M Jul 31, 2021 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.